NAMPT and chronic kidney disease: In the context of CKD, visfatin/Nampt promoted fibrosis in rat mesangial cells by upregulating the synthesis of key profibrotic molecules such as transforming growth factor-β1 (TGF-β1), PAI-1 and type I collagen, thus increasing the risk for CVD [111].